Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Immediate priority: Patient safety and regulatory compliance. The signal for liver failure (serious, life-threatening adverse event) triggers obligations under FDA post-marketing requirements (21 CFR 314.80/600.80 for expedited reporting of serious unexpected events, typically within 15 days of awareness for…Read the full answer
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer